Manipal Health Enterprises IPO Details
Manipal Health Enterprises IPO Summary
Manipal Health Enterprises IPO opens for subscription on 29 Jul 2026 and closes on 31 Jul 2026.The IPO will be listed on NSE, BSE with the tentative listing date set for 05 Aug 2026.
Manipal Health Enterprises IPO price band has been fixed at ₹560 – ₹590 per share. The face value is ₹2 per share with a lot size of 25.
Manipal Health Enterprises IPO total issue size comprises 15,72,33,715 shares (aggregating up to ₹9276.79 Cr). This includes a fresh issue of 13,56,19,881 shares (aggregating up to ₹8001.57 Cr). Offer for Sale consists of 2,16,13,834 shares (aggregating up to ₹1275.22 Cr). Pre-issue shareholding stands at 1,17,97,57,321, which will increase to 1,31,53,50,541 post-issue.
Manipal Health Enterprises IPO carries a ₹7 (1.19%) GMP, reflecting investor sentiment.
Manipal Health Enterprises IPO Lot Size :Retail Minimum is 1 lot (25 shares) amounting to ₹14,750. Retail Maximum is 13 lots (325 shares) amounting to ₹191,750. SHNI Minimum is 14 lots (350 shares) amounting to ₹206,500. SHNI Maximum is 67 lots (1,675 shares) amounting to ₹988,250. BHNI Minimum is 68 lots (1,700 shares) amounting to ₹1,003,000.
Manipal Health Enterprises IPO Details
Manipal Health Enterprises IPO Subscription
Manipal Health Enterprises IPO Application Wise Breakup (Approx)
Manipal Health Enterprises IPO Dates
- 29 Jul 2026Opening dateOpen
- 31 Jul 2026Closing dateClose
- 03 Aug 2026Allotment Date Allotment
- 04 Aug 2026Initiation of RefundsRefund
- 04 Aug 2026Credit of SharesCredit
- 05 Aug 2026Listing dateListing
Manipal Health Enterprises IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 25 | ₹14,750 |
| Retail Maximum | 13 | 325 | ₹191,750 |
| SHNI Minimum | 14 | 350 | ₹206,500 |
| SHNI Maximum | 67 | 1675 | ₹988,250 |
| BHNI Minimum | 68 | 1700 | ₹1,003,000 |
Manipal Health Enterprises IPO Reservation
Promoter Holding
Documents
Manipal Health Enterprises IPO Valuations
Manipal Health Enterprises Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 24,864.50 | 14,072.08 | 10,818.83 |
| Total Income | 10,520.52 | 8,362.79 | 6,265.17 |
| Profit After Tax | 916.52 | 1,081.67 | 533.20 |
| EBITDA | 2,795.94 | 2,247.07 | 1,776.60 |
| NET Worth | 8,440.92 | 5,865.66 | 4,029.22 |
| Reserves and Surplus | 8,204.96 | 5,788.60 | 3,953.59 |
| Total Borrowing | 10,553.43 | 4,766.83 | 3,943.98 |
| Amount in ₹ Crore | |||
About Manipal Health Enterprises IPO
Incorporated in 2010, Manipal Health Enterprises Limited is a healthcare service providers, operating a large network of multi-specialty hospitals, clinics, and diagnostic centres across the country. It is part of the Manipal Group, founded by T. M. A. Pai.vThe company offers a wide range of healthcare services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare. Its hospitals are equipped with advanced medical technology and are staffed by experienced medical professionals.
Manipal Health focuses on delivering quality, patient-centric care and expanding access to healthcare through strategic acquisitions, partnerships, and continuous investment in medical infrastructure and digital health initiatives. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds. They are operating 21 clinics as of March 31, 2026.
As of March 31, 2026, the company had 24,240 full-time employees across its hospitals and corporate functions. The workforce comprised 11,048 nurses, 6,362 paramedics, and 6,830 administrative employees, supporting its healthcare operations and patient services.
Strength Of Manipal Health Enterprises IPO
- India's largest multispecialty hospital group by bed capacity with pan-India presence and leadership in our three key regions.
- We are the only private hospital chain network in India with leadership in three metros (Bengaluru, Kolkata and Pune) with a balanced and diversified presence across metros and non-metros.
- Widely recognized brand and network of choice for patients, doctors and healthcare professionals.
- Advanced infrastructure and medical equipment, with a strong focus on clinical excellence.
- Track record of delivering industry leading growth with strong profitability and efficiency metrics.
- Repeatable playbook for integrating and scaling transformative acquisitions to improve access to quality healthcare.
- Experienced leadership team with marquee institutional shareholder support.
Risk Of Manipal Health Enterprises IPO
- A substantial number of our hospitals are located in Karnataka. We derived 46.40%, 51.55%, and 59.98%, of our revenue from operations in Fiscals 2026, 2025 and 2024, respectively, from our hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical or policy changes in Karnataka could have a material adverse effect on our business, financial condition, results of operations, cash flows and prospects.
- We primarily generate revenue by providing inpatient care at our hospitals. Any inability to maintain or improve our admissions and hospital occupancy rates could adversely affect our business, financial condition, results of operations, cash flows and prospects.
- We derived 64.30%, 62.56% and 61.55% of our gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences ("CONGO-R") specialties in Fiscals 2026, 2025 and 2024, respectively, and any negative changes in the demand for these specialties could adversely impact our business, results of operations and financial condition.
- A portion of the Net Proceeds is proposed to be utilized for repayment or prepayment of certain borrowings in the nature of Non-Convertible Debentures issued by one of our Subsidiaries to DBS Bank Ltd., which is the parent company of DBS Bank India Limited, which is deemed to be an "associate" of Imperius Healthcare Investments Pte. Ltd. (one of our Promoters and Selling Shareholders) in terms of Regulation 21A of SEBI Merchant Bankers Regulations.
- Acquisitions, strategic investments, partnerships or alliances may be difficult to identify, acquire and integrate, and may adversely affect our business, financial condition, results of operations, cash flows and prospects.
- We are exposed to legal claims and regulatory actions arising from the provision of healthcare services which includes claims arising out of alleged medical negligence by our doctors and other healthcare professionals and may be subject to liabilities arising from operational and equipment-related risks, which could materially and adversely affect our reputation, business, financial position, and results of operations. Further, quarantines and sterilizations could limit the operations of hospitals and result in reputational damage.
- Any failure to maintain and enhance our brand and reputation, and any negative publicity and allegations in the media against us, may adversely affect the level of trust in our services and market recognition, which could have an adverse impact on our business, financial condition, results of operations, cash flows and prospects.
- We are required to obtain, renew and maintain statutory and regulatory permits, licenses and accreditations and comply with prescribed quality standards. Any regulatory changes or violations of such rules and regulations, or failure to obtain or renew approvals, licenses, registrations and permits to operate our business or comply with prescribed quality standards in a timely manner, or at all, may adversely affect our business, financial condition, results of operations, cash flows and prospects.
- Our operations involve the generation and handling of bio-medical waste and are subject to pollution control laws and regulations. Any failure to comply with applicable bio-medical waste management and pollution control laws and regulations could adversely affect our business, results of operations, financial condition and cash flows.
- We derived 49.68%, 49.18% and 49.45% of our gross inpatient revenue from insurance and third-party administrators in Fiscals 2026, 2025 and 2024, respectively. Termination, non-renewal, delay or difficulties in collection or any breach of the conditions of our contracts with insurance and third-party administrators, as well as from government and other non-cash payors, could have a material adverse impact on our business, financial condition, results of operations, cash flows and prospects.
Objectives Manipal Health Enterprises IPO
1. Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited
2. Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited
3. General corporate purposes
Company Contact Details
The Annexe, #98/2, Rustom Bagh, HAL Airport Road,
Bengaluru, Karnataka , 560017
Phone: +9180 4936 0300
Email: legalcs@manipalhospitals.com
Website: https://www.manipalhospitals.com/
Registrar Contact Details
Lead Mangers
- Kotak Mahindra Capital Company Ltd(Past IPO Performance)
- Axis Capital Ltd(Past IPO Performance)
- Goldman Sachs (India) Securities Pvt Ltd(Past IPO Performance)
- Jefferies India Pvt Ltd(Past IPO Performance)
- JP Morgan India Pvt Ltd(Past IPO Performance)
- Ubs Securities India Pvt Ltd(Past IPO Performance)
- DBS Bank India Ltd(Past IPO Performance)
- IPO Lead Manager Performance Summary
Manipal Health Enterprises FAQs
The Manipal Health Enterprises IPO is a MAINBOARD public issue comprising 157233715 equity shares with a face value of ₹2 each, aggregating to a total issue size of ₹9276.79 Cr. The issue price has been fixed at ₹590 per equity share, and the minimum application size is 25 shares.
The IPO opens for subscription on 29 Jul 2026, and closes on 31 Jul 2026.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at ₹7 (1.19%).
Quick Links
Comments
